General Information of Drug (ID: DME2AZG)

Drug Name
US10150740, Example 1 Drug Info
Synonyms SCHEMBL18425452; US10150740, Example 1; BDBM307505
Cross-matching ID
PubChem CID
126508802
TTD Drug ID
DME2AZG

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US10087167, Compound 4001 DMAP1DN N. A. N. A. Patented [2]
US10087167, Compound 3002 DMM6WAB N. A. N. A. Patented [2]
US10150740, Example 4 DMKM93Q N. A. N. A. Patented [1]
US10150740, Example 9 DM1VPLU N. A. N. A. Patented [1]
US8877733, 27 DMDN8P1 N. A. N. A. Patented [3]
US10087167, Compound 3003 DMITOY6 N. A. N. A. Patented [2]
US8877733, 28 DMLY3RE N. A. N. A. Patented [3]
ISIS 11155 DMB31GR Discovery agent N.A. Investigative [4]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hepatitis C virus Core protein messenger RNA (HCV Core mRNA) TTQFZWR POLG_HCV1 Inhibitor [1]

References

1 6,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infection. US10150740.
2 Benzofurans substituted with secondary benzamide as HCV inhibitors. US10087167.
3 1-substituted pyrimidine N-nucleoside analogs for antiviral treatment. US8877733.
4 US patent application no. 6,391,542, Compositions and methods for treatment of Hepatitis C virus-associated diseases.